ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
36 announcements with these filters
Sagility Limited informs shareholders that dividend payments have been processed. Shareholders with rejected payments must update KYC details with their DPs to receive withheld funds.
Sagility Limited reported the re-appointment of Mr. Hari Gopalakrishnan as a Non-Executive Non-Independent Director following his retirement by rotation at the 5th Annual General Meeting.
Sagility Limited conducted its 5th Annual General Meeting on August 20, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and approval of final dividends.
Sagility reported Q1 FY27 revenue of INR 19,635M, up 27.6% YoY. Strategy focuses on AI-led orchestration via the Synchrony platform and clinical service expansion through the CareSeed acquisition.
Sagility Ltd has issued the notice for its 5th Annual General Meeting scheduled for August 20, 2026. The company provided the annual report for FY 2025-26.
Sagility Limited has approved the re-appointment of PricewaterhouseCoopers Services LLP as Internal Auditor for an 18-month term starting October 1, 2026.
Sagility Limited has re-appointed PricewaterhouseCoopers Services LLP as its internal auditor for the period from October 1, 2026, to March 31, 2028.
Sagility reported Q1 FY27 revenue of ₹1,963.5 Crore, up 27.6% YoY. Adjusted PAT grew 35.1% to ₹269.7 Crore, driven by strong operational performance.
Sagility Limited announced its board approved unaudited financial results for the quarter ended June 30, 2026. The meeting concluded on July 21, 2026.
Sagility reported strong Q1 FY27 results with 27.6% YoY revenue growth. Strategic focus remains on healthcare Payer operations, augmented by the acquisition of CareSeed for quality operations.
Sagility Ltd reported revenue from operations of ₹1,964 Cr (+27.6% YoY) and net profit of ₹216.8 Cr (+45.9% YoY) for Q1 FY27.
Sagility Limited submitted its registered ESOP Trust Deed for the 'ESOS 2026' scheme. The trust will administer employee stock options and performance stock units.
Sagility Limited scheduled a board meeting on July 21, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Sagility Limited recommended the re-appointment of Mr. Hari Gopalakrishnan as Non-Executive Non-Independent Director. The proposal is subject to shareholder approval at the upcoming AGM.
Sagility Limited scheduled its AGM for August 20, 2026. The company fixed August 07, 2026, as the record date for determining final dividend entitlements.
Sagility Ltd filed its ESOP Trust Deed to set up an employee stock option scheme. The trust’s initial corpus is Rs.10,000 (0.001 Crore).
Sagility Ltd partially redeemed ₹149.5 Crore in NCDs. Interest for April-July 2026 was also paid to the debenture holder.
Sagility Ltd announced the voting results of a Postal Ballot. All resolutions, including the Employee Stock Options Scheme, were duly passed.
Sagility Limited acquired 100% of US-based Careseed LLC for ₹304 Crore. The deal strengthens healthcare analytics and quality measurement capabilities within the U.S. payer ecosystem.
Sagility acquired CareSeed, a U.S. healthcare analytics firm, for an undisclosed sum. The deal strengthens its Medicare Advantage and AI-led quality operations capabilities.
Sagility is acquiring CareSeed for up to ₹28.5 Crore to boost healthcare analytics. This strengthens its payer ecosystem and quality measurement capabilities.
Sagility Limited received a ₹0.90 Crore GST demand order from Karnataka tax authorities including interest and penalties. The company intends to appeal the order.
Sagility Limited issued a postal ballot notice seeking shareholder approval for its 2026 employee stock option scheme. Remote e-voting commences on May 30, 2026.
Sagility Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. The report confirms full regulatory compliance with no new observations.
Sagility Limited received a rectified income tax demand of ₹56.68 Crore for AY 2023-24. The company has filed an appeal contesting the transfer pricing adjustments.
Sagility Ltd. reported strong FY26 performance with 29.1% revenue growth to ₹71,929 million. Strategy focuses on AI-led healthcare operations and expanding mid-market client presence.
Sagility reported Q1 FY26 revenue of ₹15,389M (up 25.8% YoY) and adjusted EBITDA of ₹3,687M, maintaining 24% margins despite seasonality.
Sagility Ltd reported revenue from operations of ₹2,024 Cr (+29.1% YoY) and net profit of ₹257.7 Cr (+41.1% YoY) for Q4 FY26.
Sagility Limited recommended a final dividend of ₹0.10 per equity share for 2026. This distribution rewards shareholders following the board's meeting approval.
Sagility Limited's Board approved the Employee Stock Options and Performance Stock Units Scheme 2026, covering 15.45 crore shares. The scheme represents 3.30% of current paid-up capital.